Impact of Unapproved Drug Initiative on Colchicine Use
NCT02000232 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 185
Last updated 2022-08-10
Summary
Measure if FDA regulation of Colchicne in 2009 has resulted in safer use in clinical settings.
Our study will assess the impact of this Initiative on colchicine use and will provide data that supports its continuation and expansion.
Conditions
Sponsors & Collaborators
- lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2014-09-30
- Completion
- 2014-09-30
Countries
- United States
Study Locations
More Related Trials
-
Mechanistic Effects of Colchicine in Patients With Myocardial Infarction
NCT02995512 ·Status: WITHDRAWN ·Phase: PHASE4
-
MPC-004 for the Treatment of an Acute Gout Flare
NCT00506883 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout
NCT02252835 ·Status: COMPLETED ·Phase: PHASE2
-
Study of of URC102 to Assess the Efficacy and Safety in Gout Patients
NCT04804111 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Colchicine and Nonsteroidal Anti-inflammatory Drug Combination Therapy and Renal Function in Gout Patients
NCT05006001 ·Status: UNKNOWN
-
A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout
NCT01736514 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Colchicine for the Prevention of Gout Flares During the Initiation of Allopurinol
NCT01451645 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients
NCT02290210 ·Status: COMPLETED ·Phase: PHASE2
-
Study of URC102 to Assess the Safety and Efficacy in Gout Patients
NCT02557126 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Oral Febuxostat in Subjects With Gout
NCT02082769 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout
NCT01336686 ·Status: COMPLETED ·Phase: PHASE2
-
Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate
NCT04511702 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia
NCT03934099 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Colchicine Among Patients With COVID-19 Infection
NCT04867226 ·Status: COMPLETED ·Phase: PHASE2
-
Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients
NCT01416402 ·Status: COMPLETED ·Phase: PHASE2
-
Revisiting the Mechanism of the Anti-inflammatory Effect of Colchicine
NCT04355585 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients
NCT05119686 ·Status: COMPLETED ·Phase: PHASE2
-
Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010
NCT00175019 ·Status: COMPLETED ·Phase: PHASE3
-
Drug Use Study of Febuxostat After Recent Changes in the Prescribing Information
NCT04853160 ·Status: COMPLETED
-
Center of Research Translation (CORT) Project 2
NCT02038179 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Prednisolone Versus Colchicine for Acute Gout in Primary Care
NCT05698680 ·Status: TERMINATED ·Phase: PHASE4
-
Colchicine in COVID-19: a Pilot Study
NCT04375202 ·Status: TERMINATED ·Phase: PHASE2
-
Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19)
NCT04355143 ·Status: COMPLETED ·Phase: PHASE2
-
Bucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe Gout
NCT02330796 ·Status: COMPLETED ·Phase: PHASE2
-
Rasburicase Treatment in Chronic Gouty Arthritis
NCT05312268 ·Status: UNKNOWN ·Phase: PHASE4